Hiroshi Nakase - Publications

Personalized and stratified therapy in ulcerative colitis:what is feasible at present and how far have we advanced?

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: July 12, 2026

Inflammasomes in Intestinal Inflammation: Guardians of Mucosal Homeostasis, Amplifiers of Disease, and Targets for Intervention.

Journal: Internal medicine (Tokyo, Japan)

Published: July 05, 2026

Serum soluble Fas levels and incidence of biliary tract cancer in a nested case-control study.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 27, 2026

Exploratory comparison of immune cell compositions across organs in IgG4-related disease.

Journal: Modern rheumatology

Published: May 26, 2026

New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by REFINED-ASUC.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: May 11, 2026

Correction: Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study).

Journal: Journal of gastroenterology

Published: April 10, 2026

Efficacy and safety of upadacitinib for Crohn's disease in patients in East Asia: a post hoc analysis of randomized phase 3 studies.

Journal: Journal of gastroenterology

Published: April 07, 2026

Infliximab-Associated IgA Vasculitis Masquerading as Crohn's Disease Relapse: Leukocytoclastic Vasculitis Confirmed on Duodenal Biopsy - A Case Report.

Journal: Inflammatory intestinal diseases

Published: April 02, 2026

Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort.

Journal: Crohn's & colitis 360

Published: March 20, 2026

Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort.

Journal: Inflammatory intestinal diseases

Published: February 18, 2026

Cutaneous Lesions of IgG4-related Disease.

Journal: Internal medicine (Tokyo, Japan)

Published: February 01, 2026

Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulators or advanced therapies: post hoc analysis of the phase 2/3 J-True North study.

Journal: Intestinal research

Published: January 23, 2026